Amplification-Free Dye-Labeled Digital Immunoassay: From Subpicomolar to Attomolar
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c02352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Baiyuan Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Fluorescent Dyes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Government of Jiangsu Province, National Natural Science Foundation of China, "343" Industry Development Project of Xuzhou.
Abstract (Originalsprache)
Signal tags are critical for a successful single-molecule counting assay and digital immunoassay (DIA). Compared to enzymes, nucleic acid fragments, and micro/nanoparticles, dye molecules offer some advantages: they are amplification-free, have minimal steric hindrance, have high disperse uniformity, and have less aggregation. However, existing dye-labeled digital immunoassays have low detection sensitivities, failing to detect neurological biomarkers in the blood. Here, we present an ultrasensitive, amplification-free DIA based on dye labeling and the synergistic sedimentation (SynSed). The dynamic range for GFAP measurement spans from 0.015 to 10 fM with excellent linear relationship (R2 > 0.99), covering nearly 3 orders of magnitude. The LOD is as low as 5.7 aM, and the intra- and interbatch variation reach 6.54% and 9.63% respectively. The quantitative results of plasma samples reveal that the median plasma GFAP levels in both Alzheimer's disease (AD, 1.44 pM, p < 0.0001) and Parkinson's disease (PD, 0.67 pM, p < 0.001) patients are significantly higher than that in the healthy controls (0.06 pM), and a notable difference is also observed between the AD and PD patient groups (p < 0.01). This SynSed assisted dye-labeled DIA possesses high sensitivity, stability, and specificity, offering a promise for early neurodegenerative disease screening, therapeutic monitoring, and risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China.
- Department of Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
ORCID-Profile: Hongwei Gai
Förderung
- Government of Jiangsu Province
- National Natural Science Foundation of China
- "343" Industry Development Project of Xuzhou
Zitieren
APA
Zhao, B., Pan, X., Zhang, Q., & Gai, H. (2025). Amplification-Free Dye-Labeled Digital Immunoassay: From Subpicomolar to Attomolar. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c02352
Vancouver
Zhao B, Pan X, Zhang Q, Gai H. Amplification-Free Dye-Labeled Digital Immunoassay: From Subpicomolar to Attomolar. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c02352
BibTeX
@article{Zhao2025,
author = {Zhao, Baiyuan and Pan, Xiaoyan and Zhang, Qingquan and Gai, Hongwei},
title = {Amplification-Free Dye-Labeled Digital Immunoassay: From Subpicomolar to Attomolar},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c02352}
}
EUVIMED